New Protomol (Core B4) core to study enzyme in some kinds of cancer
We’ve been using our new Protomol (Core B4) core to study the activation of src Kinase, an enzyme that is involved in the onset of some kinds of cancer.
Read moreCategory: Cancer
New software methods for the chaperonin inhibitor project
Del has been involved in the development of new software methods (Ocker) for the chaperonin inhibitor project.
Read moreDel has presented his plans to the NIH Nanomedicine center
Del has presented his plans to the NIH Nanomedicine center with a very positive response. Planning for the lab side of this work has begun.
Read morePlans for fighting cancer with FAH
Plans have started to take a new approach for using FAH to fight cancer: to develop novel chaperonin inhibitors. FAH researcher Del Lucent is taking the lead. See this blog…
Read morep53 presentation
FAH researcher Dr. Lillian Chong presented her work on p53 at a lecture at several US Universities.
Read morep53: two sets of projects completed and two new papers for peer review
Two new sets of projects have completed and two new papers are being readied for peer-reviewed publication.
Read moreInteresting results from p53 projects
We are getting some interesting results from recent new FAH p53 projects.
Read moreExpanding p53
We are expanding FAH’s p53 work to other related p53 systems
Read moreFirst work on cancer
Our first work on cancer has recently been published.
Read more